Eur. J. Cancer

FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response.

Bogatyrova O, Mattsson JSM, Ross EM, ..., Esdar C, Micke P

Eur. J. Cancer 151 (-) 136-149 [2021-07-00; online 2021-05-10]

NGI Stockholm (Genomics Applications) NGI Stockholm (Genomics Production) National Genomics Infrastructure

An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.

Tsakonas G, Lewensohn R, Botling J, ..., Hydbring P, Ekman S

Eur. J. Cancer 132 (-) 24-34 [2020-06-00; online 2020-04-20]

Bioinformatics Support for Computational Resources [Service] Clinical Genomics [Collaborative] Clinical Genomics Uppsala [Collaborative]

Breast cancer in young women and prognosis: How important are proliferation markers?

Fredholm H, Magnusson K, Lindström LS, ..., Frisell J, Fredriksson I

Eur. J. Cancer 84 (-) 278-289 [2017-10-00; online 2017-08-29]

Tissue Profiling [Collaborative]